Related Experiment Video
Updated: Nov 30, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Ischemic colitis and short bowel disease due to choronavirus disease 2019 (COVID 19)
Paloma González Lázaro1, Amparo Lomas Meneses1, Florentino Del Val Zaballos1
1Department of Endocrninology and Nutrition, La Mancha Centro Hospital, Spain.
Insights
This case report highlights ischemic colitis as the initial symptom of COVID-19 infection in a patient with diabetes and hypercholesterolemia. It underscores the gastrointestinal manifestations of coronavirus disease 2019 and its link to coagulopathy.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Hematology
Background:
- Coronavirus disease 2019 (COVID-19) presents with diverse symptoms, including pulmonary and increasingly recognized gastrointestinal manifestations.
- COVID-19-associated coagulopathy is a significant factor contributing to high morbidity and mortality.
- Ischemic colitis is linked to hypercoagulable states, but its association with COVID-19 is rarely reported.
Observation:
- A 53-year-old male with type 2 diabetes and hypercholesterolemia presented with ischemic colitis.
- This presentation preceded the diagnosis of COVID-19 infection.
- The patient's ischemic colitis was the first clinical manifestation of COVID-19.
Findings:
- The case illustrates ischemic colitis as an early sign of COVID-19.
- This highlights the importance of considering COVID-19 in patients presenting with gastrointestinal issues, especially those with vascular risk factors.
- The findings suggest a potential link between COVID-19, coagulopathy, and ischemic colitis.
Implications:
- Early recognition of gastrointestinal symptoms like ischemic colitis in the context of COVID-19 is crucial.
- This case expands the understanding of COVID-19's clinical spectrum and its association with thrombotic events.
- Further research is needed to elucidate the mechanisms linking COVID-19, coagulopathy, and ischemic colitis.
Abstract:
COVID-19 has spread worldwide, with more than 2.5 million cases and over 80,000 deaths reported by the end of April 2020. In addition to pulmonary symptoms, gastrointestinal symptoms have been increasingly recognized as part of the disease spectrum. COVID-19-associated coagulopathy has recently emerged as a major component of the disease, leading to high morbidity and mortality. Ischemic colitis has been reported to be associated with a hypercoagulable state, However few cases have been reported of COVID-19 associated with ischemic colitis. We would like to report a case of a 53 year old man with medical history of type 2 diabetes, and hypercholesterolemia, with ishchemic colitis as first manifestation of infection of COVID 19.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

